Spectral AI Inc
Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. It is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.
Stock Performance Snapshot
Analyst Rating
Analysts strongly recommend buying Spectral AI's stock as it is expected to rise significantly.
Financial Health
Spectral AI Inc is earning good money and generating cash, showing positive financial performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring MDAI
Nvidia Intel Partnership: Beyond the $5B Deal
Nvidia announced a $5 billion investment in Intel, marking a significant partnership between the two semiconductor rivals to jointly develop AI-focused chips. This collaboration could create opportunities for other companies in the semiconductor supply chain and AI software development.
Published: September 19, 2025
Explore BasketPerformance-Linked AI Leadership Explained
Tesla's proposal of a massive, performance-linked pay package for Elon Musk highlights its aggressive growth strategy. This move, which also involves investment in Musk's xAI, creates an investment theme centered on companies that tie executive incentives to ambitious innovation and AI expansion.
Published: September 8, 2025
Explore BasketMobile AI's Antitrust Challenge
Elon Musk's companies are suing Apple and OpenAI, alleging their partnership creates an anti-competitive monopoly in the AI space. This legal battle could unlock the mobile AI market for competitors, creating a significant growth opportunity for other AI technology firms.
Published: August 27, 2025
Explore BasketThe AI Partnership Playbook
Meta is licensing Midjourney's leading AI image generation technology to enhance the creative tools across its social media apps. This strategic partnership highlights a growing industry trend of collaboration, creating investment opportunities among companies that provide specialized AI models and the essential infrastructure that supports them.
Published: August 25, 2025
Explore BasketCybersecurity's M&A Boom
Accenture's record-breaking acquisition of CyberCX signals a major consolidation trend in the cybersecurity sector. This move highlights the growing value of specialized firms, creating potential opportunities among other companies in the AI-driven security and threat intelligence space.
Published: August 16, 2025
Explore BasketHealthcare's Efficiency Imperative
UnitedHealth Group's recent profit miss, driven by high medical costs, has triggered a major cost-cutting initiative across the company. This move signals a broader industry trend, creating an investment opportunity in companies that provide AI and technology solutions to help healthcare organizations improve efficiency and reduce operational expenses.
Published: July 30, 2025
Explore BasketAI Governance And Compliance Technology
This carefully selected group of stocks focuses on companies helping businesses navigate the complex world of AI regulations. As tensions rise between tech giants and regulators, these companies provide the essential tools and services organizations need to stay compliant and avoid costly penalties.
Published: July 21, 2025
Explore BasketAI Compliance Divergence: RegTech Solutions for EU Standards
This carefully selected group of stocks represents companies at the forefront of AI governance and compliance solutions. Our professional analysts have identified these opportunities emerging from the regulatory divide between tech giants like Microsoft and Meta, as businesses increasingly need specialized help to navigate complex AI rules.
Published: July 20, 2025
Explore BasketAI-Driven Drug Discovery
These groundbreaking companies are redefining pharmaceutical research with artificial intelligence. Each has been carefully selected by our analysts for their potential to develop life-saving drugs faster and more efficiently than traditional methods allow.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Small-cap growth potential
AI and imaging themes can offer growth opportunities; however, small‑cap stocks are often volatile and may experience sharp declines.
Technology and execution
If the firm commercialises AI‑driven spectral solutions, industry tailwinds could help—but execution, customer adoption and funding are key risks.
Research and liquidity
Public disclosures and trading volume may be limited; investors should review filings and consider liquidity before taking a position.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
